Cosmetics/Diversified Stock Analysis: 1998
This article was originally published in The Rose Sheet
1998 Performance Of Toiletries, Fragrances And Skin Care Stocks (12 Cosmetics and 11 Diversified) Used In The Weekly "The Rose Sheet" Index: High, Low And Close For The Yea
You may also be interested in...
In addition to our daily in-depth coverage of key events relating to the COVID-19 pandemic, we’re bringing you a periodic round-up of other developments. This edition covers Europe and other countries.
EU drug industry federation, EFPIA, is concerned that an increase in protectionist trade measures by some countries could result in tit-for-tat policies that could hamper the global response to contain COVID-19.
Pfizer has received European Commission approval for the firm’s Ruxience biosimilar to Roche’s MabThera brand, including as a treatment for rheumatoid arthritis, opening the door to a three-way biosimilar fight in the European Union.